Tuberculosis - new and relapse cases in Iran
Iran: Tuberculosis - new and relapse cases was 7,033 in 2024. ▼ Falling
Latest (2024)
7,033
Change on year
down 5.3%
World rank
72nd
of 197 countries
All-time high
11,850
in 2000
All-time low
5,993
in 2020
Years of data
25
2000–2024
Tuberculosis - new and relapse cases in Iran, 2000–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, tuberculosis - new and relapse cases in Iran stood at 7,033.
The figure is down 5.3% on the previous year and down 31.0% over ten years.
Over the whole period, tuberculosis - new and relapse cases in Iran peaked at 11,850 in 2000 and was at its lowest, 5,993, in 2020.
Iran ranks 72nd of 197 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 25 years of available data.
Tuberculosis - new and relapse cases in Iran, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 11,850 | — |
| 2001 | 11,783 | -0.6% |
| 2002 | 11,464 | -2.7% |
| 2003 | 10,900 | -4.9% |
| 2004 | 10,171 | -6.7% |
| 2005 | 9,212 | -9.4% |
| 2006 | 9,361 | +1.6% |
| 2007 | 9,316 | -0.5% |
| 2008 | 9,453 | +1.5% |
| 2009 | 10,097 | +6.8% |
| 2010 | 10,362 | +2.6% |
| 2011 | 10,980 | +6.0% |
| 2012 | 11,042 | +0.6% |
| 2013 | 11,052 | +0.1% |
| 2014 | 10,191 | -7.8% |
| 2015 | 10,215 | +0.2% |
| 2016 | 9,252 | -9.4% |
| 2017 | 9,051 | -2.2% |
| 2018 | 8,906 | -1.6% |
| 2019 | 8,524 | -4.3% |
| 2020 | 5,993 | -29.7% |
| 2021 | 6,199 | +3.4% |
| 2022 | 7,261 | +17.1% |
| 2023 | 7,425 | +2.3% |
| 2024 | 7,033 | -5.3% |
Iran compared with similar countries
- Iran's 7,033 is above the median for upper middle income countries, which is 2,589, 2.7× the median. (57 countries reporting)
- Iran's 7,033 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 2,597, 2.7× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10,361 | 9,212 | 11,850 | 10 |
| 2010s | 9,958 | 8,524 | 11,052 | 10 |
| 2020s | 6,782 | 5,993 | 7,425 | 5 |
Countries ranked near Iran
More health data for Iran
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0311 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is tuberculosis - new and relapse cases in Iran?
- Tuberculosis - new and relapse cases in Iran was 7,033 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest tuberculosis - new and relapse cases recorded in Iran?
- The highest recorded value was 11,850 in 2000.
- What is the lowest tuberculosis - new and relapse cases recorded in Iran?
- The lowest recorded value was 5,993 in 2020.
- How does Iran rank for tuberculosis - new and relapse cases?
- Iran ranks 72nd out of 197 countries with data for 2024.
- Is tuberculosis - new and relapse cases rising or falling in Iran?
- Over the last ten years it is down 31.0%. The long-run trend across the full record is falling.
- Where does this Iran data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Tuberculosis - new and relapse cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).